Living Donor Liver Transplantation for Pediatric Patients with Inheritable Metabolic Disorders

Shneider, 2002, Pediatric liver transplantation in metabolic disease: clinical decision making, Pediatr Transplant, 6, 25, 10.1034/j.1399-3046.2002.1p057.x

Burdelski, 2002, Liver transplantation in metabolic diseases: current status, Pediatr Transplant, 6, 361, 10.1034/j.1399-3046.2002.2e031.x

Asonuma, 1999, Living related liver transplantation from heterozygote genetic carriers to children with Wilson's disease, Pediatr Transplant, 3, 201, 10.1034/j.1399-3046.1999.00014.x

Morioka D, Takada Y, Kasahara M et al. Living donor liver transplantation for non-cirrhotic inheritable metabolic liver diseases: impact of the use of heterozygous donors. Transplantation 2005 (in press).

Kasahara, 1998, Treatment of ornithine transcarbamylase deficiency in girls by auxiliary liver transplantation: conceptual changes in living‐donor program, J Pediatr Surg, 33, 1753, 10.1016/S0022-3468(98)90278-0

Yorifuji, 2000, Living‐related liver transplantation for neonatal‐onset propionic acidemia, J Pediatr, 137, 572, 10.1067/mpd.2000.108391

Kasahara, 2004, Functional portal flow competition after auxiliary partial orthotopic living donor liver transplantation in noncirrhotic metabolic liver disease, J Pediatr Surg, 39, 1138, 10.1016/j.jpedsurg.2004.03.079

Whitington, 1998, Liver transplantation for the treatment of urea cycle disorders, J Inherit Metab Dis, 21, S112, 10.1023/A:1005317909946

Russo, 2001, Tyrosinemia: a review, Pediatr Dev Pathol, 4, 212, 10.1007/s100240010146

Matern, 1999, Liver transplantation for glycogen storage disease types I, III and IV, Eur J Pediatr, 158, S43, 10.1007/PL00014320

Bove, 2004, Bile acid synthetic defects and liver disease: a comprehensive review, Pediatr Dev Pathol, 7, 315, 10.1007/s10024-002-1201-8

Do, 2002, Benefits of chronic plasmapheresis and intravenous heme‐albumin in erythropoietic protoporphyria after orthotopic liver transplantation, Transplantation, 73, 469, 10.1097/00007890-200202150-00024

Morimoto, 1996, Guidelines for donor selection and an overview of the donor operation in living related liver transplantation, Transpl Int, 9, 208, 10.1111/j.1432-2277.1996.tb00881.x

Fujita, 2000, Hepatic grafts from live donors: donor morbidities for 470 cases of liver donation, Transpl Int, 13, 333, 10.1111/j.1432-2277.2000.tb01006.x

Hauser, 1990, Allopurinol‐induced orotiduria. A test for mutaions at the ornithine carbamoyltransferase locus in women, N Eng J Med, 322, 1641, 10.1056/NEJM199006073222305

Arranz, 1999, Optimization of allopurinol challenge: sample purification, protein intake control and the use of orotidine response as a discriminative variable improve performance of the test for diagnosing ornithine carbamoyltransferase deficiency, Clin Chem, 45, 995, 10.1093/clinchem/45.7.995

Yorifuji, 1998, X‐inactivation pattern in the liver of a manifesting female with ornithine transcarbamylase (OTC) deficiency, Clin Genet, 54, 349, 10.1034/j.1399-0004.1998.5440415.x

Egawa, 2004, Impact of age on outcome of ABO‐incompatible living donor liver transplantation, Transplantation, 77, 403, 10.1097/01.TP.0000110295.88926.5C

Miyagawa‐Hayashino, 2004, Outcome and risk factors of de novo autoimmune hepatitis in living‐donor liver transplantation, Transplantation, 78, 128, 10.1097/01.TP.0000132328.33460.43

Do, 2002, Benefits of chronic plasmapheresis and intravenous heme‐albumin in erythropoietic protoporphyria after orthotopic liver transplantation, Transplantation, 73, 469, 10.1097/00007890-200202150-00024

Dellon, 2002, Treatment of recurrent allograft dysfunction with intravenous hematin after liver transplantation for erythropoietic protoporphyria, Transplantation, 73, 911, 10.1097/00007890-200203270-00014

Van't Hoff, 1998, Combined liver‐kidney transplantation in methylmalonic academia, J Pediatr, 132, 1043, 10.1016/S0022-3476(98)70407-X

Bhattacharya, 2004, The benefits of liver transplantation in glycogenosis type Ib, J Inherit Metab Dis, 27, 539, 10.1023/B:BOLI.0000037400.49488.20

Chou, 2002, Type I glycogen storage diseases: disorders of the glucose‐6‐phosphate complex, Curr Mol Med, 2, 121, 10.2174/1566524024605798

Stankovics, 1994, Overexpression of human methylmalonic CoA mutase in mice after in vivo gene transfer with asialoglycoprotein/ polylysine/ DNA complexes, Hum Gene Ther, 5, 1095, 10.1089/hum.1994.5.9-1095

Richard, 2004, Hematopoietic stem cell gene therapy of murine protoporphyria by methylguanine‐DNA‐methyltransferase‐mediated in vivo drug selection, Gene Ther, 11, 1638, 10.1038/sj.gt.3302335

Broelsch, 1990, Application of reduced‐size liver transplants as split grafts, auxiliary orthotopic grafts and living related segmental transplants, Ann Surg, 212, 368, 10.1097/00000658-199009000-00015

Kasahara, 2003, Living‐donor liver transplantation with monosegments, Transplantation, 76, 694, 10.1097/01.TP.0000079446.94204.F9

Yersiz, 2003, One‐hundred in situ split‐liver transplantations: a single‐center experience, Ann Surg, 238, 496, 10.1097/01.sla.0000089852.29654.72

Ito, 2003, Surgery‐related morbidity in living donors of right‐lobe liver graft: lessons from the first 200 cases, Transplantation, 76, 158, 10.1097/01.TP.0000072372.42396.47

Akabayashi, 2004, The first donor death after living‐related liver transplantation in Japan, Transplantation, 77, 634, 10.1097/01.TP.0000115342.98226.7C

Plochl, 1999, Death after transplantation of a liver from a donor with unrecognized ornithine transcarbamylase deficiency, N Engl J Med, 341, 921, 10.1056/NEJM199909163411214